Age-related maculopathy: a risk indicator for poorer survival in women: the Copenhagen City Eye Study.
暂无分享,去创建一个
G. Jensen | J. Prause | M. la Cour | T. Vinding | N. Nielsen | H. Buch
[1] G. Jensen,et al. 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. , 2005, Ophthalmology.
[2] A. Grigorian. ASSOCIATIONS OF MORTALITY WITH OCULAR DISORDERS AND AN INTERVENTION OF HIGH-DOSE ANTIOXIDANTS AND ZINC IN THE AGE-RELATED EYE DISEASE STUDY , 2004 .
[3] T. Clemons,et al. Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13. , 2004, Archives of ophthalmology.
[4] Usha Chakravarthy,et al. Prevalence of age related maculopathy in northern India , 2004 .
[5] A. Hofman,et al. Is there a direct association between age-related eye diseases and mortality? The Rotterdam Study. , 2003, Ophthalmology.
[6] R. Klein,et al. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. , 2003, Ophthalmology.
[7] A. Hofman,et al. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. , 2003, Archives of ophthalmology.
[8] J. Seddon,et al. Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. , 2002, American journal of ophthalmology.
[9] R. Klein,et al. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.
[10] Paul Mitchell,et al. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. , 2002, Ophthalmology.
[11] T. Vinding,et al. Prevalence and causes of visual impairment according to World Health Organization and United States criteria in an aged, urban Scandinavian population: the Copenhagen City Eye Study. , 2001, Ophthalmology.
[12] M. la Cour,et al. The prevalence and causes of bilateral and unilateral blindness in an elderly urban Danish population. The Copenhagen City Eye Study. , 2001, Acta ophthalmologica Scandinavica.
[13] Louis Pizzarello. Lens Opacities and Mortality: The Barbados Eye Studies , 2001 .
[14] J. J. Wang,et al. Visual impairment, age-related cataract, and mortality. , 2001, Archives of ophthalmology.
[15] H. Taylor,et al. Vision impairment predicts 5 year mortality , 2001, The British journal of ophthalmology.
[16] G. Rubin,et al. Mixed lens opacities and subsequent mortality. , 2000, Archives of ophthalmology.
[17] R. Kington,et al. The relationship of self-rated vision and hearing to functional status and well-being among seniors 70 years and older. , 1999, American journal of ophthalmology.
[18] K. Dietz,et al. Mortality in Blind Subjects , 1998, Ophthalmologica.
[19] R. Cumming,et al. Visual Impairment and Falls in Older Adults: The Blue Mountains Eye Study , 1998, Journal of the American Geriatrics Society.
[20] J. J. Wang,et al. Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. , 1997, Australian and New Zealand journal of ophthalmology.
[21] J. Manson,et al. Postmenopausal hormone therapy and mortality. , 1997, The New England journal of medicine.
[22] P. Dargent-Molina,et al. Sensory impairments and physical disability in aged women living at home. , 1996, International journal of epidemiology.
[23] J. J. Wang,et al. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. , 1995, Ophthalmology.
[24] T. Sellers,et al. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. , 1995, American journal of public health.
[25] I. Dielemans,et al. Macular degeneration and early menopause: a case-control study , 1995, BMJ.
[26] R. Klein,et al. Age-related eye disease and survival. The Beaver Dam Eye Study. , 1995, Archives of ophthalmology.
[27] A. MacDonald. Modelling Survival Data in Medical Research. By D. Collett (Chapman & Hall, 1994) £19.99 , 1995, British Actuarial Journal.
[28] R. Klein,et al. Is age-related maculopathy associated with cataracts? , 1994, Archives of ophthalmology.
[29] D. Clayton,et al. Statistical Models in Epidemiology , 1993 .
[30] J. Thompson,et al. Cataract and survival in an elderly nondiabetic population. , 1993, Archives of ophthalmology.
[31] G. Frisoni,et al. Sensory Impairment and Quality of Life in a Community Elderly Population , 1993, Journal of the American Geriatrics Society.
[32] R. Klein,et al. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. , 1992, Ophthalmology.
[33] William D. Spector,et al. The Relationship of Vision and Hearing Impairment to One-Year Mortality and Functional Decline , 1992 .
[34] R. Klein,et al. The Wisconsin age-related maculopathy grading system. , 1991, Ophthalmology.
[35] C. Jagger,et al. The association between visual impairment and mortality in elderly people. , 1989, Age and ageing.
[36] B. Bengtsson. SURVIVAL OF ELDERLY OPHTHALMIC OUT‐PATIENTS , 1984, Acta ophthalmologica.
[37] Maltzman Ba,et al. Senile macular degeneration and risk factors: a case-control study. , 1979, Annals of ophthalmology.
[38] P. Schnohr,et al. [The Copenhagen City Heart Study. A prospective cardiovascular population study of 20,000 men and women]. , 1977, Ugeskrift for laeger.
[39] E. Rogot,et al. Survivorship and causes of death among the blind. , 1966, Journal of chronic diseases.
[40] C. Walker. Ophthalmology , 1859, Bristol medico-chirurgical journal.
[41] Paul Mitchell,et al. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. , 2007, Ophthalmology.
[42] P. Schnohr. The Copenhagen City Heart Study : Østerbroundersøgelsen : tables with data from the third examination 1991-1994 , 2001 .
[43] H R Taylor,et al. Vision impairment predicts five-year mortality. , 2000, Transactions of the American Ophthalmological Society.
[44] W. Browner,et al. Association Between Depressive Symptoms and Mortality in Older Women , 2000 .
[45] R. Cumming,et al. Sensory impairment and driving: the Blue Mountains Eye Study. , 1999, American journal of public health.
[46] E L Korn,et al. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. , 1997, American journal of epidemiology.
[47] K Bandeen-Roche,et al. Function and visual impairment in a population-based study of older adults. The SEE project. Salisbury Eye Evaluation. , 1997, Investigative ophthalmology & visual science.
[48] R. Klein,et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[49] J. Alsina. Benefits of hormone replacement therapy--overview and update. , 1997 .
[50] J M Gibson,et al. Seven year follow-up of age-related maculopathy in an elderly British population , 1997, Eye.
[51] T. Vinding. Age-related macular degeneration. An epidemiological study of 1000 elderly individuals. With reference to prevalence, funduscopic findings, visual impairment and risk factors. , 1995, Acta ophthalmologica Scandinavica. Supplement.
[52] W. D. Ray. 4. Modelling Survival Data in Medical Research , 1995 .
[53] R. Klein,et al. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. , 1994, Transactions of the American Ophthalmological Society.
[54] D. Collett. Modelling survival data , 1994 .
[55] R. Klein,et al. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. , 1992, Ophthalmology.